Key result
VAD successfully bridges pediatric mixed LVNC and restrictive cardiomyopathy to heart transplantation.
Why the study?
Left ventricular noncompaction cardiomyopathy exhibits wide genotypic and phenotypic variability, with rare restrictive phenotypes lacking detailed clinical reports.
Case Report (n=1)
Supports VAD bridging in rare pediatric mixed cardiomyopathy; leaves open broader applicability and genotype-specific outcomes.
Left ventricular noncompaction cardiomyopathy (LVNC) is a rare form of heritable cardiomyopathy with wide genotypic variability, numerous phenotypic variations, and a wide spectrum of clinical disease from asymptomatic to end stage heart failure. Here, we present a case of a 2-year-old boy who presented to their pediatrician with a cough as a first clinical sign of heart failure, rapidly progressing to severe heart failure. He was found to have mixed LVNC with a restrictive phenotype, a rare phenotype of this form of cardiomyopathy. Eventually, the patient was supported via mechanical circulation with a Berlin Heart EXCOR® ventricular assist device as bridge to successful cardiac transplantation. Genetic testing for inherited cardiomyopathies found a mutation in MYH7 (Arg369Gln), known to be associated with various forms of cardiomyopathy, but has not been reported in restrictive LVNC.
No takes yet. Share an insight, caveat, or question.
Morrison et al. (2020) conducted a case report in Mixed Left Ventricular Non-Compaction and Restrictive Cardiomyopathy (n=1). Berlin Heart EXCOR ventricular assist device was evaluated on Successful bridge to heart transplantation. A 23-month-old boy with mixed left ventricular non-compaction and restrictive cardiomyopathy and a novel MYH7 (Arg369Gln) mutation was successfully bridged to heart transplantation using a ventricular assist device.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: